Developing new vaccines for infectious diseases and bioterrorism
Vaccine Manufacturing and Characterization Services
['FUNDING_OTHER'] · IDT BIOLOGIKA GMBH · NIH-9746965
This study is all about creating new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IDT BIOLOGIKA GMBH (nih funded) |
| Locations | 1 site (DESSAU-ROSSLAU, GERMANY) |
| Trial ID | NIH-9746965 on ClinicalTrials.gov |
What this research studies
This research focuses on the manufacturing and characterization of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism and drug-resistant pathogens. It involves a comprehensive approach that includes product development planning, optimization, and compliance with regulatory standards for clinical studies. Patients may benefit from the development of new vaccines that are specifically designed to address emerging health threats. The research also includes the production of vaccine components and delivery systems.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those affected by drug-resistant pathogens.
Not a fit: Patients with established vaccines for their conditions or those not at risk for infectious diseases may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against serious infectious diseases and bioterrorism threats.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
DESSAU-ROSSLAU, GERMANY
- IDT BIOLOGIKA GMBH — DESSAU-ROSSLAU, GERMANY (ACTIVE)
Researchers
- Principal investigator: NEUBERT, ANDREAS — IDT BIOLOGIKA GMBH
- Study coordinator: NEUBERT, ANDREAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Emerging Infectious Diseases, Emerging Communicable Diseases